In vivo calpain/caspase cross-talk during 3-nitropropionic acid-induced striatal degeneration: implication of a calpain-mediated cleavage of active caspase-3.
about
Calpain 10: a mitochondrial calpain and its role in calcium-induced mitochondrial dysfunctionMouse models of Huntington's disease and methodological considerations for therapeutic trials.The dual role of calcium as messenger and stressor in cell damage, death, and survival.Calpain cleavage of brain glutamic acid decarboxylase 65 is pathological and impairs GABA neurotransmission.Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone.The kinder side of killer proteases: caspase activation contributes to neuroprotection and CNS remodelingpH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study.Caspase-dependent and -independent neuronal death: two distinct pathways to neuronal injury.Proteolytic mechanisms in necrotic cell death and neurodegeneration.Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancerPromethazine protects against 3-nitropropionic acid-induced neurotoxicity.Cardiac arrest triggers hippocampal neuronal death through autophagic and apoptotic pathways.Ginsenosides: are any of them candidates for drugs acting on the central nervous system?OGG1 is degraded by calpain following oxidative stress and cisplatin exposureCalpain-mediated signaling mechanisms in neuronal injury and neurodegenerationSuccinobucol, a Lipid-Lowering Drug, Protects Against 3-Nitropropionic Acid-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Cells via Upregulation of Glutathione Levels and Glutamate Cysteine Ligase Activity.Effect of copper overload on the survival of HepG2 and A-549 human-derived cells.Calpain plays a central role in 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in cerebellar granule neurons.The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins.Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs.Human structural proteome-wide characterization of Cyclosporine A targets.ICP10PK inhibits calpain-dependent release of apoptosis-inducing factor and programmed cell death in response to the toxin MPP+.Caspase-3 and calpain activities after acute and repeated ethanol administration during the rat brain growth spurt.Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington's disease.Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.Lack of Jun-N-terminal kinase 3 (JNK3) does not protect against neurodegeneration induced by 3-nitropropionic acid.Hypochlorous acid induces apoptosis of cultured cortical neurons through activation of calpains and rupture of lysosomes.Expression pattern of ataxia telangiectasia mutated (ATM), p53, Akt, and glycogen synthase kinase-3β in the striatum of rats treated with 3-nitropropionic acid.
P2860
Q24294402-738CCA7D-9224-408E-AB52-D658CC82D6DDQ30481208-2D36F21B-FB4A-4C55-A0E8-D02547542B24Q33726729-C943E185-9DCC-4500-B054-087553124243Q34200288-B2283DE3-1E78-4CE0-ACF8-4CE65203FE6EQ35287240-E1A4517E-E7DC-403E-A5E8-0D238C0A4CC4Q35683839-962A8125-E2C9-4123-80A1-2335FD856F24Q35939218-6A0CCF55-7521-4927-97A7-DF26CA881746Q35999742-8F3F4790-E9B1-4D57-9CFE-6736DA669A55Q36156010-28F6F2E4-F622-4AE5-B1B9-8639CADE8A09Q36166608-9608B2EA-3D3D-4DA9-AD45-C2A30D21B885Q36253348-8C4FABFA-3B6C-4D6D-BE3B-C9C3238B2835Q36980419-179B69EB-2D9E-4BF8-8465-970862B46104Q37031566-7F8FF835-6ADB-4905-A048-D6C9DA5B9CC7Q37234084-1FD4E494-7972-4B0A-947A-4A1CF959CEA4Q37237452-41E31A1D-6920-4AE5-9E3D-B517E85DB476Q38916576-27B4FC0C-9912-4D6E-B467-A632DAC3C342Q39296050-037219CE-DBDF-419A-9E7E-6D7135936C69Q39723688-29F2029E-7946-4348-AA26-F9D949D84432Q39792514-5BAE9881-6703-48BE-9996-AFFED84F7255Q40026363-7CC2132B-D1E6-436B-AC7C-A52CAD36C155Q42185186-B7CC839A-FBBD-4013-BF57-44428509C58CQ42565249-39A4ED97-D1D0-4B23-9FC1-4B141B027BF6Q44804978-03A2E89C-589B-41F5-A213-6CBA19B13A60Q45297523-F5822EB1-EEEC-4308-94E8-891C0E7AE5E3Q45303268-618AF262-F887-484F-83C3-E746C209A192Q45304129-9B9E6589-0DCB-4D85-BE42-BA6D6AC4E803Q48440996-A87F9F00-8AC4-48CB-BF1F-7E2A07737E68Q48567266-E5EF2714-42B4-43E7-A12D-CDC09084CAF0
P2860
In vivo calpain/caspase cross-talk during 3-nitropropionic acid-induced striatal degeneration: implication of a calpain-mediated cleavage of active caspase-3.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
In vivo calpain/caspase cross- ...... cleavage of active caspase-3.
@en
In vivo calpain/caspase cross- ...... cleavage of active caspase-3.
@nl
type
label
In vivo calpain/caspase cross- ...... cleavage of active caspase-3.
@en
In vivo calpain/caspase cross- ...... cleavage of active caspase-3.
@nl
prefLabel
In vivo calpain/caspase cross- ...... cleavage of active caspase-3.
@en
In vivo calpain/caspase cross- ...... cleavage of active caspase-3.
@nl
P2093
P2860
P50
P356
P1476
In vivo calpain/caspase cross- ...... cleavage of active caspase-3.
@en
P2093
Carine Jacquard
Christophe Créminon
Frédéric Saudou
Nicolas Bizat
Philippe Hantraye
Sandrine Humbert
Stan Krajewski
P2860
P304
43245-43253
P356
10.1074/JBC.M305057200
P407
P577
2003-08-12T00:00:00Z